日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study

Dupilumab治疗花生过敏儿童的疗效和安全性:一项多中心、开放标签的II期研究

Sindher, Sayantani B; Nadeau, Kari C; Chinthrajah, R Sharon; Leflein, Jeffrey G; Bégin, Philippe; Ohayon, Jason A; Ponda, Punita; Wambre, Erik; Liu, Jinzhong; Khokhar, Faisal A; Akinlade, Bolanle; Maloney, Jennifer; Orengo, Jamie M; Hamilton, Jennifer D; Kamal, Mohamed A; Hooper, Andrea T; Patel, Naimish; Patel, Kiran; Laws, Elizabeth; Mannent, Leda P; Radin, Allen R

Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy

度普利尤单抗作为花生过敏患儿口服免疫疗法的辅助治疗

Chinthrajah, R Sharon; Sindher, Sayantani B; Nadeau, Kari C; Leflein, Jeffrey G; Spergel, Jonathan M; Petroni, Daniel H; Jones, Stacie M; Casale, Thomas B; Wang, Julie; Carr, Warner W; Shreffler, Wayne G; Wood, Robert A; Wambre, Erik; Liu, Jinzhong; Akinlade, Bolanle; Atanasio, Amanda; Orengo, Jamie M; Hamilton, Jennifer D; Kamal, Mohamed A; Hooper, Andrea T; Patel, Kiran; Laws, Elizabeth; Mannent, Leda P; Adelman, Daniel C; Ratnayake, Anoshie; Radin, Allen R

Divergent T Cell Phenotypes Define Pediatric Crohn's Disease and Ulcerative Colitis.

不同的 T 细胞表型定义了儿童克罗恩病和溃疡性结肠炎。

Nettey Leonard, Zheng Hengqi Betty, Devlin Joseph C, Horowitz Julie E, Rosenbaum Sara, Fiaschi Nathalie, Lim Wei Keat, Kimler Kyle, Adler Christina, Lee Annabelle, Ni Min, Wei Yi, Ehmann Peter J, McCarthy Shane E, Ferreira Manuel A R, Galbavy William, Stahl Eli, Haxhinasto Sokol, Coetzee Sandra, Yabe Yoko, Dobosz Michael, Keskula Paula, Zavistaski Jillian, Albanese Alexandre, Steier Zoë, de Sousa Casal Joshua, Niederlova Veronika, Ambartsumyan Lusine, Wahbeh Ghassan, Suskind David L, Mitsialis Vanessa, Hamon Sara, Carpenter Stephen M, Hamilton Jennifer D, Shalek Alex K, Snapper Scott B, Sleeman Matthew A, Kalliolias George D, Hooper Andrea T, Ordovas-Montanes Jose, Kean Leslie S

Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19.

CAS+IMD单克隆抗体混合物对COVID-19住院患者的潜在免疫调节作用

Wang Bei, Golubov Jacquelynn, Oswald Erin M, Poon Patrick, Wei Qiaozhi, Lett Clarissa, Shehadeh Fadi, Kaczynski Matthew, Felix Lewis Oscar, Mishra Biswajit, Mylona Evangelia K, Wipperman Matthew F, Chio Erica, Hamon Sara C, Hooper Andrea T, Somersan-Karakaya Selin, Musser Bret J, Petro Christopher D, Hamilton Jennifer D, Sleeman Matthew A, Kalliolias George D, Mylonakis Eleftherios, Skokos Dimitris

Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19

卡西利维单抗和伊姆维维单抗(CAS + IMD)在COVID-19儿科门诊患者中的安全性和药代动力学

Norton, Thomas D; Thakur, Mazhar; Ganguly, Samit; Ali, Shazia; Chao, Jesse; Waldron, Alpana; Xiao, Jing; Turner, Kenneth C; Davis, John D; Irvin, Susan C; Pan, Cynthia; Atmodjo, Dominique; Hooper, Andrea T; Hamilton, Jennifer D; Hussein, Mohamed; Subramaniam, Danise; Roque-Guerrero, Lilia; Kohli, Anita; Mylonakis, Eleftherios; Geba, Gregory P; Cox, Edward; Braunstein, Ned; Dakin, Paula; Kowal, Bari; Bhore, Rafia; DiCioccio, A Thomas; Hughes, Diana; Herman, Gary A

Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study

评估卡西利维单抗和伊姆维维单抗(CAS+IMD)在COVID-19妊娠门诊患者队列中的安全性和药代动力学:一项适应性、多中心、随机、双盲、1/2/3期研究的结果

Norton, Thomas D; Thakur, Mazhar; Ganguly, Samit; Ali, Shazia; Chao, Jesse; Waldron, Alpana; Xiao, Jing; Patel, Yogesh; Turner, Kenneth C; Davis, John D; Irvin, Susan C; Pan, Cynthia; Atmodjo-Watkins, Dominique; Hooper, Andrea T; Hamilton, Jennifer D; Subramaniam, Danise; Bocchini, Joseph A; Kowal, Bari; DiCioccio, A Thomas; Bhore, Rafia; Geba, Gregory P; Cox, Edward; Braunstein, Ned; Dakin, Paula; Herman, Gary A

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

研究接种疫苗或单克隆抗体后SARS-CoV-2中和抗体的保护作用

Follmann, Dean; O'Brien, Meagan P; Fintzi, Jonathan; Fay, Michael P; Montefiori, David; Mateja, Allyson; Herman, Gary A; Hooper, Andrea T; Turner, Kenneth C; Chan, Kuo- Chen; Forleo-Neto, Eduardo; Isa, Flonza; Baden, Lindsey R; El Sahly, Hana M; Janes, Holly; Doria-Rose, Nicole; Miller, Jacqueline; Zhou, Honghong; Dang, Weiping; Benkeser, David; Fong, Youyi; Gilbert, Peter B; Marovich, Mary; Cohen, Myron S

Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles

卡西利维单抗联合伊维维单抗可加速症状缓解,并改善易感抗体和风险人群的 COVID-19 预后。

Li, Dateng; Xu, Meng; Hooper, Andrea T; Rofail, Diana; Mohammadi, Kusha A; Chen, Yiziying; Ali, Shazia; Norton, Thomas; Weinreich, David M; Musser, Bret J; Hamilton, Jennifer D; Geba, Gregory P

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial

卡西利维单抗和伊姆维维单抗抗体联合治疗免疫功能低下住院冠状病毒病患者的疗效:一项 1/2/3 期双盲试验的事后分析

Somersan-Karakaya, Selin; Mylonakis, Eleftherios; Mou, Jenni; Oviedo-Orta, Ernesto; O'Brien, Meagan P; Mas Casullo, Veronica; Mahmood, Adnan; Hooper, Andrea T; Hussein, Mohamed; Ali, Shazia; Marty, Francisco M; Forleo-Neto, Eduardo; Bhore, Rafia; Hamilton, Jennifer D; Herman, Gary A; Hirshberg, Boaz; Weinreich, David M

Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection

鼻咽病毒载量是SARS-CoV-2感染后抗体免疫反应的主要驱动因素

Xu, Meng; O'Brien, Meagan P; Hooper, Andrea T; Forleo-Neto, Eduardo; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Cohen, Myron S; Marovich, Mary A; Hamilton, Jennifer D; Hirshberg, Boaz; Herman, Gary A; Musser, Bret J